Health Insurance & Protection has teamed up with Primal Pictures, also part of Informa, to share the cutting-edge stills, animations and video it has developed about COVID-19, in order to give a greater understanding to you and your clients about the devastating pandemic that is affecting them, their businesses – and yours.
The following is just a small portion from Primal Pictures’ 3D Disease & Conditions unique and ever-expanding library of still images, animations and full guided videos on a range of diseased anatomy.
Healthcare providers (HCPs) face the challenge of finding accurate same-source content for consistent communication to patients of normal and diseased anatomy. Lack of content continuity makes reference frustrating, and education and treatment plans confusing for patients. The 3D Disease and Conditions product from Primal Pictures provides HCPs with a full workflow solution.
To discover how the 3D Disease and Conditions product can enhance patient education, save time and improve health outcomes, please request a call back.
About Primal Pictures: Established in 1991, Primal Pictures create and publish the world’s most medically accurate and detailed 3D graphic rendering of human anatomy based on imaging data.
Coronavirus disease 2019 (COVID-19) is a highly infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This is a new illness which targets the respiratory system.
Spread of the disease is transmitted via respiratory droplets through coughing or sneezing.
Follow government guidelines to stay safe and prevent COVID-19 from spreading.
Some COVID-19 patients are asymptomatic, meaning they don’t have any symptoms despite testing positive for the disease. Mild symptoms occur in the majority of cases (~80%) and include a continuous cough and fever. More severe symptoms include shortness of breath, known as dyspnea, which can indicate pneumonia. A small proportion of critical cases (<5%) can result in respiratory failure, septic shock or multiple-organ failure.
Explore the region
Drag the image to rotate the anatomy
COVID-19 initially affects parts of the upper respiratory tract.
Infection of the upper respiratory tract results in mild symptoms such as a fever and a dry, continuous cough.
A fever is thought to develop as the immune system enhances to fight the virus and inhibit its further spread.
COVID-19 can spread to the lower respiratory tract.
Infection of the lower respiratory tract affects tertiary branches of the bronchi known as the bronchioles, the air passages of the lungs.
The bronchioles become inflamed and irritated, causing a cough.
In more severe cases, the virus can travel further down the respiratory tract, affecting the alveoli, the air sacs of the lungs.
This may lead to a condition called pneumonia, which is characterised by inflammation of the alveoli and the build-up of fluid.
There is currently no cure for COVID-19 and treatments aim to manage the underlying symptoms of the disease.
Respiratory support may be required for patients with severe pneumonia.
Antibiotics do not help as the disease has a viral cause, not bacterial.
Anti-inflammatory medications should be avoided.